Post CCB, Westermann AM, Boere IA, Witteveen PO, et al. Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial). Gynecol Oncol 2022 Mar 11. pii: S0090-8258(22)00145.
PMID: 35287967